These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8738541)

  • 1. Lipoprotein abnormalities in chronic renal failure and dialysis patients.
    Monzani G; Bergesio F; Ciuti R; Rosati A; Frizzi V; Serruto A; Vitali D; Benucci A; Tosi PL; Bandini S; Salvadori M
    Blood Purif; 1996; 14(3):262-72. PubMed ID: 8738541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and apolipoproteins change during the progression of chronic renal failure.
    Bergesio F; Monzani G; Ciuti R; Serruto A; Benucci A; Frizzi V; Salvadori M
    Clin Nephrol; 1992 Nov; 38(5):264-70. PubMed ID: 1451339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins.
    Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T
    Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal concentrations of CII, CIII, and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients.
    Alsayed N; Rebourcet R
    Clin Chem; 1991 Mar; 37(3):387-93. PubMed ID: 2004445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation of the Apo Al-CIII-AIV gene cluster in hypertriglyceridemic patients with chronic renal failure undergoing hemodialysis.
    Choi GR; Suh SP; Song JW; Kee SJ; Shin JH; Ryang DW
    J Korean Med Sci; 2000 Jun; 15(3):289-94. PubMed ID: 10895970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum apolipoprotein profile of hypertriglyceridemic patients with chronic renal failure on hemodialysis: a comparison with type IV hyperlipoproteinemic patients.
    Averna MR; Barbagallo CM; Galione A; Carroccio A; Labisi M; Marino G; Montalto G; Notarbartolo A
    Metabolism; 1989 Jul; 38(7):601-2. PubMed ID: 2739572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.
    Wakabayashi Y; Okubo M; Shimada H; Sato N; Koide A; Marumo F; Nakamura H
    Metabolism; 1987 Sep; 36(9):815-20. PubMed ID: 3626863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein AI and apolipoprotein B containing particle analysis in normolipidemic hemodialyzed patients: evidence of free apolipoprotein E.
    Kandoussi AM; Hugue V; Parra HJ; Dracon M; Fruchart JC; Tacquet A; Cachera C
    Am J Nephrol; 1996; 16(4):287-92. PubMed ID: 8739280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO; Alaupovic P
    Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia in patients with chronic renal failure and in renal transplant patients.
    Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG
    J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uremic dyslipidemia: a cross-sectional and longitudinal study.
    Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
    Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in lipoproteins induced by the remnant kidney tissue or binephrectomy in chronic uremic patients treated by hemodialysis.
    Robert D; Jeanmonod R; Favre H; Fruchart JC; Sturzenegger E; Riesen W
    Metabolism; 1989 Jun; 38(6):514-21. PubMed ID: 2498613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein metabolism and renal failure.
    Attman PO; Samuelsson O; Alaupovic P
    Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure.
    Attman PO; Alaupovic P; Tavella M; Knight-Gibson C
    Nephrol Dial Transplant; 1996 Jan; 11(1):63-9. PubMed ID: 8649654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E.
    Clavey V; Lestavel-Delattre S; Copin C; Bard JM; Fruchart JC
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):963-71. PubMed ID: 7600129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII.
    Hirano T; Sakaue T; Misaki A; Murayama S; Takahashi T; Okada K; Takeuchi H; Yoshino G; Adachi M
    Kidney Int; 2003 Jun; 63(6):2171-7. PubMed ID: 12753304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.